Corcovado Pharmaceuticals. Corcovado Pharmaceutical's cost of debt is 6.60%. The risk-free rate of interest is 4.00%. The expected return on the market portfolio is 8.50%. Corcovado's effective tax rate is 39%. Its optimal capital structure is 55% debt and 45% equity. a. If Corcovado's beta is estimated at 1.40, what is its weighted average cost of capital? b. If Corcovado's beta is estimated at 1.00, significantly lower because of the continuing profit prospects in the global pharma sector, what is its weighted average cost of capital